This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Express Scripts seeks stay in Acthar antitrust case

( November 2, 2020, 22:31 GMT | Official Statement) -- MLex Summary: Express Scripts has asked a US federal judge to stay a case accusing it of illegally maintaining a monopoly over adrenocorticotropic hormone drugs by purchasing a competing synthetic. Express Scripts asked for the stay pending the resolution of bankruptcy proceedings against Mallinckrodt, which it says deals with at least three issues that bear on the case against it.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents